Ocean Biomedical Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

M. Berrey

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	less than a year
CEO sahipliği	n/a
Yönetim ortalama görev süresi	2.2yrs
Yönetim Kurulu ortalama görev süresi	3.7yrs

Son yönetim güncellemeleri

Recent updates

CEO

M. Berrey (57 yo)

less than a year

Görev süresi

Dr. M. Michelle Berrey, M.D., M.P.H., is Interim Chief Executive Officer and Director of Ocean Biomedical, Inc. from October 23, 2024. She served as President of Research & Development and Chief Medical Of...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Inderjote Kathuria	Chief Strategy Officer	3.3yrs	Veri yok	Veri yok
Chirinjeev Kathuria	Founder & Executive Chairman of the Board	5.8yrs	Veri yok	1.32% € 315.9k
M. Berrey	Interim CEO & Director	less than a year	Veri yok	Veri yok
Jack Elias	Founder	no data	Veri yok	0% € 0
Jonathan Kurtis	Founder	no data	Veri yok	0% € 0
Jolie Kahn	Chief Financial Officer	less than a year	Veri yok	Veri yok
Robert Sweeney	Chief Accounting Officer & Assistant Secretary	2.2yrs	Veri yok	Veri yok

2.2yrs

Ortalama Görev Süresi

59yo

Ortalama Yaş

Deneyimli Yönetim: 8AW0 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.2 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Chirinjeev Kathuria	Founder & Executive Chairman of the Board	5.8yrs	Veri yok	1.32% € 315.9k
M. Berrey	Interim CEO & Director	3.7yrs	Veri yok	Veri yok
Jack Elias	Founder	no data	Veri yok	0% € 0
Jonathan Kurtis	Founder	3.4yrs	Veri yok	0% € 0
William Koster	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Martin Angle	Independent Director	3.7yrs	Veri yok	Veri yok
Roy Steven Herbst	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
William Owens	Independent Director	3.7yrs	Veri yok	0% € 0
Wafik El-Deiry	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Erol Fikrig	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Jackie Ernst	Member of Advisory Board	no data	Veri yok	Veri yok
Bethany Solomon	Member of Advisory Board	no data	Veri yok	Veri yok

3.7yrs

Ortalama Görev Süresi

67yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 8AW0 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.7 yıldır).

Ocean Biomedical Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Insufficient new directors

Ocean Biomedical, Inc. Appoints Amy Griffith as Director

Ocean Biomedical, Inc. Appoints Amy Griffith as Director

Recent updates

Ocean Biomedical Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

New minor risk - Financial data availability

Ocean Biomedical Receives Non-Compliance Letter from Nasdaq

Ocean Biomedical, Inc. Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and Its Ability to Inhibit Anti-Tumor and Related Tissue Remodeling Responses

Ocean Biomedical, Inc. Announces Patent Issued for PfGARP Malaria Antibodies Central to Company's Malaria Treatment and Prevention Platforms

Ocean Biomedical Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Insufficient new directors

Ocean Biomedical, Inc.(NasdaqCM:OCEA) dropped from Russell 3000 Index

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Ocean Biomedical, Inc. announced delayed 10-Q filing

Ocean Biomedical Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K

Ocean Biomedical, Inc. announced delayed annual 10-K filing

Ocean Biomedical, Inc. Appoints Amy Griffith as Director

Ocean Biomedical, Inc. Appoints Amy Griffith as Director

New minor risk - Financial data availability

Ocean Biomedical Receives Non-Compliance Notice from Nasdaq

Ocean Biomedical Receives Non-Compliance Notice from Nasdaq

Ocean Biomedical Announces Publication of Breast Cancer Research Uncovering New Tumor Suppression Pathway for its Proprietary Anti-Chi3L1 Antibody

Ocean Biomedical Receives a Notice from the Nasdaq Listing Qualifications Department

Ocean Biomedical Receives a Notice from the Nasdaq Listing Qualifications Department

Ocean Biomedical, Inc. announced delayed 10-Q filing

Ocean Biomedical, Inc. Announces Positive Preclinical Oncology Data for Vron 0300, Presented At Sitc 2023 Annual Meeting, and Clinical Updates by 50/50 Joint Venture Partner Virion Therapeutics

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş